Panobinostat
Panobinostat
Panobinostat (pronounced pano-bin-o-stat) is a drug used in the treatment of various types of cancer, including multiple myeloma and cutaneous T-cell lymphoma. It is classified as a histone deacetylase inhibitor, which works by blocking the action of enzymes involved in cell division and growth.
Etymology
The name "Panobinostat" is derived from the Greek words "pan", meaning "all", and "binos", meaning "life". The suffix "-stat" is commonly used in drug nomenclature to indicate a substance that inhibits or stops a particular action.
Usage
Panobinostat is used in combination with other medications to treat certain types of cancer. It is usually given after other treatments have failed. The drug is taken orally, usually once every other day.
Side Effects
Common side effects of Panobinostat include fatigue, nausea, diarrhea, and vomiting. More serious side effects can include low blood cell counts, electrolyte imbalances, and heart problems.
Related Terms
External links
- Medical encyclopedia article on Panobinostat
- Wikipedia's article - Panobinostat
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski